Teva Pharmaceutical Industries Ltd. e OncoGenex Pharmaceuticals, Inc. hanno presentato, durante il congresso ASCO (American Society of Clinical Oncology), i risultati relativi ai tre studi con la molecola sperimentale custirsen (OGX-011/TV-1011) per la...
Questo sito usa i cookies per migliorare la tua navigabilità. Sei in accordo col loro utilizzo, ma puoi scegliere di non usarli.Accetto
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.